Added: Enzon Inc. (ENZN) Michael Price added to his holdings in Enzon Inc. by 16.65%. His purchase prices were between $10.14 and $12.48, with an estimated average price of $11.15. The impact to his portfolio due to this purchase was 0.16%. His holdings were 700,000 shares as of 03/31/2011.
Enzon Pharmaceuticals Inc. is a biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases. Enzon Inc. has a market cap of $655.05 million; its shares were traded at around $11.495 with and P/S ratio of 6.69.